Jim Cramer speaks to the CEO of Allergan, to get a better look at what Allergan shareholders can expect from the world's largest drug merger.» Read More
Rupert Murdoch tweeted that he had 'strong word' that Tribune Newspapers will be bought by a Wall Street firm.
The big U.S. defense companies have used piles of cash to increase buybacks and dividends. Now they're going to move ahead on mergers and acquisitions, say analysts.
Tribune Publishing on Monday refuted rumors that the company has put itself up for sale.
The financial heads at some of the world's largest companies remain unconvinced the Fed will make any substantial changes at its December meeting.
Danish high-end stereo and TV maker Bang & Olufsen said it had received approaches regarding a potential takeover offer, sending its shares soaring.
Any benefits to Malaysia's markets from the sale of assets by troubled 1MDB may be limited to the currency, with analysts still downbeat on stocks.
A former Goldman Sachs employee stole confidential information from the Wall Street powerhouse, USA TODAY reports.
A new takeover offer for U.S. biotech firm Baxalta would create one of the world's leading specialists in rare diseases.
EMC and VMware shareholders saw stock prices plunge after Dell bought out EMC and are now asking for changes to the deal, says Re/Code.
The deal with Pfizer and Allergan is the largest inversion transaction on record. The "Fast Money" traders discuss other potential inversion targets.
Sports platform provider Fantex pulls its IPO, so we look at what some of the next steps might be.
Pfizer is buying Allergan for about $160 billion. CNBC's Meg Tirrell reports on the reaction by lobbyists and analysts.
CVC Capital Partners and the Canada Pension Plan Investment Board have agreed to acquire Petco for about $4.6 billion.
Despite what your economics professor told you, megamergers are good for investors, says trader Jack Ablin. Here's why.
CNBC's Eamon Javers reports on the political ramifications of the proposed $160 billion Pfizer and Allegan merger.
CNBC's Meg Tirrell details the $160 billion merger between Allergan and Pfizer.
Pfizer CEO Ian Read and Allergan CEO Brent Saunders discuss their $160 billion merger and the resulting pharmaceutical powerhouse.
If Diebold closes are deal with Wincor Nixdorf, it would become the world's largest ATM maker.
Barbara Ryan, Clermont Partners, weighs in on terms of the deal which is expected to close in the second half of 2016.
CNBC's Meg Tirrell reports details of the merger which will create the world's largest pharma company to be headquartered in Dublin, Ireland.